Search results for "Dihydropyridine"

showing 10 items of 70 documents

Spectroscopic and electrochemical study of interactions between DNA and different salts of 1,4-dihydropyridine AV-153

2020

1,4-dihydropyridines (1,4-DHP) possess important biochemical and pharmacological properties, including antimutagenic and DNA-binding activity. The latter activity was first described for water-soluble 1,4-DHP with carboxylic group in position 4, the sodium salt of the 1,4-DHP derivative AV-153 among others. Some data show the modification of physicochemical properties and biological activities of organic compounds by metal ions that form the salts. We demonstrated the different affinity to DNA and DNA-protecting capacity of AV-153 salts, depending on the salt-forming ion (Na, K, Li, Rb, Ca, Mg). This study aimed to use different approaches to collate data on the DNA-binding mode of AV-153-N…

Circular dichroismGuanine030303 biophysicsIntercalation (chemistry)Biophysicslcsh:MedicineCircular dichroismG-quadruplexBiochemistryMedicinal chemistryGeneral Biochemistry Genetics and Molecular BiologyNucleobase03 medical and health scienceschemistry.chemical_compoundCircular voltammetryMoleculeDenaturation (biochemistry)DNA bindingMolecular Biology14-dihydropyridines030304 developmental biologyAV-153 salts0303 health sciencesGeneral Neurosciencelcsh:RGeneral MedicineG-quadruplexeschemistryFourier-transformed infrared spectroscopySpectrofluorimetryGeneral Agricultural and Biological SciencesDNAPeerJ
researchProduct

Metal ions modify DNA-protecting and mutagen-scavenging capacities of the AV-153 1,4-dihydropyridine.

2019

Abstract 1,4-Dihydropyridines (1,4-DHP) possess important biochemical and pharmacological properties, including antioxidant and antimutagenic activities. AV-153-Na, an antimutagenic and DNA-repair enhancing compound was shown to interact with DNA by intercalation. Here we studied DNA binding of several AV-153 salts to evaluate the impact of AV-153 modifications on its DNA binding capacity, the ability to scavenge the peroxynitrite, to protect HeLa and B-cells cells against DNA damage. Affinity of the AV-153 salts to DNA measured by a fluorescence assay was dependent on the metal ion forming a salt in position 4 of the 1,4-DHP, and it decreased as follows: Mg > Na > Ca > Li > Rb > K. AV-153-…

DihydropyridinesAntioxidantDNA RepairDNA damageHealth Toxicology and Mutagenesismedicine.medical_treatmentMetal ions in aqueous solutionIntercalation (chemistry)[SDV.CAN]Life Sciences [q-bio]/CancerMutagen02 engineering and technologymedicine.disease_causeNiacinAntioxidantsHeLa03 medical and health scienceschemistry.chemical_compoundPeroxynitrous AcidGeneticsmedicineHumansDrug InteractionsDNA Breaks Single-StrandedComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesB-Lymphocytesbiology021001 nanoscience & nanotechnologybiology.organism_classificationIntercalating AgentsRecombinant ProteinsOxidative StresschemistryMetalsBiophysicstat Gene Products Human Immunodeficiency VirusComet AssaySingle-Cell Analysis0210 nano-technologyDNAPeroxynitriteDNA DamageHeLa CellsMutation research. Genetic toxicology and environmental mutagenesis
researchProduct

DNA-binding studies of AV-153, an antimutagenic and DNA repair-stimulating derivative of 1,4-dihydropiridine.

2014

Abstract The ability to intercalate between DNA strands determines the cytotoxic activity of numerous anticancer drugs. Strikingly, intercalating activity was also reported for some compounds considered to be antimutagenic. The aim of this study was to determine the mode of interaction of DNA with the antimutagenic and DNA repair-stimulating dihydropyridine (DHP) AV-153. DNA and AV-153 interactions were studied by means of UV/VIS spectroscopy, fluorimetry and infrared spectroscopy. Compound AV-153 is a 1,4 dihydropyridine with ethoxycarbonyl groups in positions 3 and 5. Computer modeling of AV-153 and DNA interactions suggested an ability of the compound to dock between DNA strands at a sin…

DihydropyridinesBinding SitesDNA RepairMolecular StructureGuanineDNA repairStereochemistryAntimutagenic AgentsGeneral MedicineDNAToxicologyNiacinThymineRatschemistry.chemical_compoundPlasmidDNA IntercalationchemistryLiverSpectroscopy Fourier Transform InfraredAnimalsA-DNACytosineDNAChemico-biological interactions
researchProduct

Design of pharmacophoric group containing 1,4-dihydropyridine derivatives and determination of spectrum of pharmacological activities

2017

Vairākkārtīgi ir uzsvērts, ka 1,4-dihidropiridīna cikls ir viens no farmakoloģiski priviliģētām struktūrām, kas iedarbojas uz jonu kanāliem un dažādiem receptoriem, un kuru modificējot, sintezējot tās struktūras analogus, variējot aizvietotājus molekulā, būtu iespējams iegūt dažādus farmakoloģiski aktīvus savienojumus. Pētījumā ir sintezēti jauni, mērķtiecīgi dizainēti, farmakoforas grupas saturoši 1,4-dihidropiridīna atvasinājumi, sistemātiski mainot farmakoforās grupas (piridīniju un/vai propargil) un to atrašanās vietu molekulā. Izvērtēts sintezēto savienojumu farmakoloģiskās darbības spektrs (aktivitāte uz kalcija kanāliem, antiradikālā aktivitāte un reducējošā kapacitāte), veidots stru…

Farmaceitiskā ķīmijacalcium channel activityPharmacophoreantiradical activitypropargyl grouppyridiniumFarmācijananoparticlesPharmacyReducing capacityPharmaceutical chemistry14-dihydropyridines
researchProduct

Evaluation of Physicochemical Properties of Amphiphilic 1,4-Dihydropyridines and Preparation of Magnetoliposomes

2021

This study was focused on the estimation of the targeted modification of 1,4-DHP core with (1) different alkyl chain lengths at 3,5-ester moieties of 1,4-DHP (C12, C14 and C16)

General Chemical EngineeringSubstituent02 engineering and technologyphysicochemical propertiesArticlelcsh:Chemistry03 medical and health scienceschemistry.chemical_compoundAmphiphileMonolayerPolymer chemistry:NATURAL SCIENCES:Physics [Research Subject Categories]MoleculeGeneral Materials ScienceAlkyl030304 developmental biologychemistry.chemical_classificationlipid monolayers0303 health sciencesLiposomeiron oxide nanoparticles021001 nanoscience & nanotechnology3. Good healthchemistrylcsh:QD1-999magnetoliposomesPyridinium14-dihydropyridine amphiphiles0210 nano-technologyIron oxide nanoparticlesNanomaterials
researchProduct

A Novel 1,4-Dihydropyridine Derivative Improves Spatial Learning and Memory and Modifies Brain Protein Expression in Wild Type and Transgenic APPSweD…

2015

Ca2+ blockers, particularly those capable of crossing the blood-brain barrier (BBB), have been suggested as a possible treatment or disease modifying agents for neurodegenerative disorders, e.g., Alzheimer's disease. The present study investigated the effects of a novel 4-(N-dodecyl) pyridinium group-containing 1,4-dihydropyridine derivative (AP-12) on cognition and synaptic protein expression in the brain. Treatment of AP-12 was investigated in wild type C57BL/6J mice and transgenic Alzheimer's disease model mice (Tg APPSweDI) using behavioral tests and immunohistochemistry, as well as mass spectrometry to assess the blood-brain barrier (BBB) penetration. The data demonstrated the ability …

Genetically modified mouseMalePathologymedicine.medical_specialtyDihydropyridinesTime Factorsmedicine.drug_classTransgeneSpatial Learninglcsh:MedicineMice TransgenicBlood–brain barrierAnxiolyticGyrus CinguliHippocampus03 medical and health sciences0302 clinical medicineHomer Scaffolding ProteinsMemorymedicineAnimalsHumanslcsh:Science030304 developmental biology0303 health sciencesMultidisciplinaryAmyloid beta-PeptidesGlutamate Decarboxylaselcsh:RDihydropyridineWild typeBrainmedicine.disease3. Good healthMice Inbred C57BLmedicine.anatomical_structureAnti-Anxiety AgentsBlood-Brain BarrierSynaptic plasticitylcsh:QAlzheimer's diseaseCarrier ProteinsNeuroscience030217 neurology & neurosurgerymedicine.drugResearch ArticlePloS one
researchProduct

1,5-Dimethyl-2-nitrimino-1,2-dihydropyridine

2006

Methyl­ation of 5-methyl-2-nitramino­pyridine provides the title compound, C7H9N3O2, as the only product. The mol­ecule consists of two planar fragments, viz. an aromatic ring and a nitrimino substituent. The NNO2 group is twisted by 17 (2)° out of the plane of the pyridine ring. Despite a small torsion angle between these fragments, the geometry of the mol­ecule indicates the participation of the π-electrons in the C—N bond. The hydrogen bonds in the crystal structure seem to be too weak to generate any deformations observed in the mol­ecule.

Hydrogen bondSubstituentDihydropyridineGeneral ChemistryCrystal structureDihedral angleCondensed Matter PhysicsRing (chemistry)Crystallographychemistry.chemical_compoundchemistryGroup (periodic table)PyridinemedicineGeneral Materials Sciencemedicine.drugActa Crystallographica Section E Structure Reports Online
researchProduct

Binding Sites for Ca2+‐Channel Effectors and Ryanodine inPeriplaneta americana—Possible Targets for New Insecticides

1996

The calcium channel and the 'calcium release channel' of muscle membrane of the cockroach Periplaneta americana have been characterized. Biological assays with calcium channel blockers and ryanodine on different insects and acari revealed pronounced insecticidal effects with ryanodine, but not with calcium channel blockers, at concentrations between 0.1 and 300 μg ml -1 . Skeletal muscle membranes derived either from the tubular network or from the sarcoplasmatic reticulum of P. americana were characterized with respect to the binding of the dihydropyridine (DHP) [ 3 H]isradipine (PN 200-110), the phenylalkylamine [ 3 H]verapamil and the alkaloid [ 3 H]ryanodine. Preliminary binding studies…

IsradipineChemistryRyanodine receptorPhenylalkylamine bindingCalcium channelDihydropyridinemedicineVerapamilCalcium Channel BindingPharmacologyLigand (biochemistry)Applied Microbiology and Biotechnologymedicine.drugPesticide Science
researchProduct

Studies of Preparation and Stability of Liposomes Formed by 1,1'-[(3,5-didodeciloxycarbonyl-4-phenyl-1,4-dihydropyridine-2,6-diil)-dimethylen]Bispyri…

2013

In this work we describe the studies of preparation and stability of liposomes formed by 1,1'-[(3,5-didodeciloxycarbonyl-4-phenyl-1,4-dihydropyridine-2,6-diil) dimethylebispyridinium dibromide, novel lipid-like compound. The influence of the amount of amphiphilic compound, solvent and sonication time was studied. Liposomes were prepared by dispersing of compound in the corresponding media at a selected concentration by sonication using a probe type sonicator and characterised by atomic force microscopy (AFM) and dynamic light scattering (DLS) methods.

LiposomeChemistryAtomic force microscopySonicationGeneral EngineeringDihydropyridineProbe typeSolventDynamic light scatteringAmphiphilemedicineOrganic chemistrymedicine.drugNuclear chemistryAdvanced Materials Research
researchProduct

Memory-enhancing and brain protein expression-stimulating effects of novel calcium antagonist in Alzheimer’s disease transgenic female mice

2016

The prevalence of Alzheimer's disease (AD) is higher in females than in males, and causes more severe cognitive, memory and behavioral impairments. Previously, in male transgenic (Tg) APPSweDI mice, we reported that the novel lipophilic 1,4-dihydropyridine (DHP) derivative AP-12 crossed the blood-brain barrier, blocked neuronal and vascular calcium channels, changed brain protein expression and improved behavior. In this study, we used female Tg APPSweDI mice to assess the effects of AP-12 on behavior, and brain protein expression, with a particular focus on those of the GABAergic system. The results showed that in female Tg mice, similar to male Tg mice, AP-12 improved spatial learning/mem…

Male0301 basic medicineCingulate cortexDihydropyridinesmedicine.medical_specialtyElevated plus mazeVesicular Inhibitory Amino Acid Transport ProteinsHippocampusMice TransgenicWater mazeBiologyHippocampal formationGyrus CinguliHippocampusArticleAmyloid beta-Protein PrecursorMice03 medical and health sciences0302 clinical medicineAlzheimer DiseaseMemoryInternal medicineNeuroplasticitymedicineAnimalsGABAergic NeuronsMaze LearningPharmacologyAmyloid beta-PeptidesNeuronal PlasticityGlutamate DecarboxylaseCalcium Channel BlockersUp-RegulationDisease Models Animal030104 developmental biologyEndocrinologyAnti-Anxiety AgentsBlood-Brain BarrierSynaptic plasticityGABAergicCalciumFemale030217 neurology & neurosurgeryPharmacological Research
researchProduct